Hostname: page-component-7b7567c8c-lpg2g Total loading time: 0 Render date: 2026-11-15T16:59:13.882Z Has data issue: false hasContentIssue false

Safe sedation?

A controlled trial of “Megimated” amylobarbitone

Published online by Cambridge University Press:  08 February 2018

Richard Fox*
Affiliation:
Bethlem Royal and Maudsley Hospitals, London
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

Death due to barbiturate overdosage has been an increasing problem, rising steadily in England and Wales from a death rate of 2 per million population in 1949 to 5 per million in 1958 (1). Of 2,044 consecutive fatal poisonings studied in Denmark between 1953 and 1959, over a quarter were due to barbiturates (2). 300 tons of barbiturate are consumed in the U.S.A. every year and acute poisoning with it in that country accounts for 1,500 deaths per year (3).

Information

Type
Therapeutic Trials
Copyright
Copyright © Royal College of Psychiatrists, 1962 
Submit a response

eLetters

No eLetters have been published for this article.